• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Conformation of peptides of the secretin-VIP-glucagon family in solution.

作者信息

Bodanszky M, Bodanszky A

出版信息

Peptides. 1986;7 Suppl 1:43-8. doi: 10.1016/0196-9781(86)90162-2.

DOI:10.1016/0196-9781(86)90162-2
PMID:3018702
Abstract

The significance of a well defined molecular architecture in hormone receptor interaction and the methods available for the study of preferred conformations are discussed. The conformational freedom in glucagon is a major obstacle in the determination of its biologically relevant geometry. In the secretin molecule intramolecular forces generate a folded, partially helical conformation. In respect of long range cooperative interactions resulting in a compact molecule with secondary-tertiary structure secretin is similar to globular proteins. In VIP some characteristics of secretin and also of glucagon can be recognized. Further progress in conformation analysis can be expected from the study of rigid, cyclic analogs in which the biological activities of the parent hormones are retained or even enhanced. Such analogs have well defined conformations without external stabilization from membrane mimicking lipids. Therefore, they provide information on the biologically relevant geometry of the hormones and contribute also to our knowledge of receptor sites.

摘要

相似文献

1
Conformation of peptides of the secretin-VIP-glucagon family in solution.
Peptides. 1986;7 Suppl 1:43-8. doi: 10.1016/0196-9781(86)90162-2.
2
The receptors of the VIP family peptides (VIP, secretin, GRF, PHI, PHM, GIP, glucagon and oxyntomodulin). Specificities and identity.血管活性肠肽家族肽(血管活性肠肽、促胰液素、生长激素释放因子、胰高血糖素样肽I、胰高血糖素样肽II、胃抑肽、胰高血糖素和胃泌酸调节素)的受体。特异性与同一性。
Peptides. 1986;7 Suppl 1:89-100. doi: 10.1016/0196-9781(86)90170-1.
3
VIP binding sites on synaptosomes from rat cerebral cortex: structure-binding relationship.大鼠大脑皮质突触体上的血管活性肠肽结合位点:结构-结合关系
Peptides. 1986;7 Suppl 1:181-6. doi: 10.1016/0196-9781(86)90183-x.
4
Interaction of peptides related to VIP and secretin with guinea pig pancreatic acini.与血管活性肠肽(VIP)和促胰液素相关的肽与豚鼠胰腺腺泡的相互作用。
Am J Physiol. 1989 Feb;256(2 Pt 1):G283-90. doi: 10.1152/ajpgi.1989.256.2.G283.
5
Evolution of the growth hormone-releasing factor (GRF) family of peptides.
Growth Regul. 1992 Dec;2(4):175-91.
6
Binding of vasoactive intestinal peptide and its stimulation of adenylate cyclase through two classes of receptors in rat liver membranes. Effects of 12 secretin analogues and 2 secretin fragments.血管活性肠肽的结合及其通过大鼠肝细胞膜上两类受体对腺苷酸环化酶的刺激作用。12种促胰液素类似物和2种促胰液素片段的作用。
Biochim Biophys Acta. 1981 Nov 18;678(1):83-90. doi: 10.1016/0304-4165(81)90050-7.
7
Vasoactive intestinal peptide receptor antagonist [4Cl-D-Phe6, Leu17] VIP.
Am J Physiol. 1986 Apr;250(4 Pt 1):G553-7. doi: 10.1152/ajpgi.1986.250.4.G553.
8
Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology.血管活性肠肽、胰高血糖素样肽和促胰液素的心脏受体能够激活腺苷酸环化酶并介导变力性和变时性效应。物种差异与病理生理学。
Peptides. 1984 Mar-Apr;5(2):341-53. doi: 10.1016/0196-9781(84)90232-8.
9
Speculations on the mechanism of hormone-receptor interactions of the secretin/glucagon family of polypeptide hormones derived from computational structural studies.
Ann N Y Acad Sci. 1996 Dec 26;805:172-81; discussion 181-3. doi: 10.1111/j.1749-6632.1996.tb17482.x.
10
Receptors for vasoactive intestinal peptide and secretin on small intestinal epithelial cells.小肠上皮细胞上的血管活性肠肽和促胰液素受体。
Am J Physiol. 1980 Mar;238(3):G190-6. doi: 10.1152/ajpgi.1980.238.3.G190.

引用本文的文献

1
Structure-activity relationship of vasoactive intestinal peptide (VIP): potent agonists and potential clinical applications.血管活性肠肽(VIP)的构效关系:强效激动剂及潜在临床应用
Naunyn Schmiedebergs Arch Pharmacol. 2008 Jun;377(4-6):579-90. doi: 10.1007/s00210-007-0232-0. Epub 2008 Jan 3.